Good is not Good Enough: The Benchmark Stroke Door-to-Needle Time Should be 30 Minutes.
1Department of Clinical Neurosciences,University of Calgary,Calgary.
Noreen
N
Kamal
8Division of Neurology, Faculty of Medicine,University of British Columbia,Vancouver,British Columbia.
Oscar
O
Benavente
10Department of Medicine,University of Toronto.
Karl
K
Boyle
5Division of Neurology,Department of Medicine,University of Alberta,Edmonton,Alberta.
Brian
B
Buck
5Division of Neurology,Department of Medicine,University of Alberta,Edmonton,Alberta.
Ken
K
Butcher
14Stroke Program,Toronto.
Leanne K
LK
Casaubon
24Department of Neurology,Neurosurgery and Medicine,McGill University.
Robert
R
Côté
1Department of Clinical Neurosciences,University of Calgary,Calgary.
Andrew M
AM
Demchuk
25Department of Neurosciences,Quebec.
Yan
Y
Deschaintre
18Departments of Medicine,Epidemiology and Community Medicine,University of Ottawa,Ottawa.
Dar
D
Dowlatshahi
27Faculty of Medicine (Neurology),Dalhousie University,Canada.
Gordon J
GJ
Gubitz
9Department of Medicine - Neurology,College of Medicine,University of Saskatchewan,Saskatoon,Saskatchewan.
Gary
G
Hunter
5Division of Neurology,Department of Medicine,University of Alberta,Edmonton,Alberta.
Tom
T
Jeerakathil
21Department of Medicine,Queen's University,London.
Albert
A
Jin
2Department of Emergency Medicine, Faculty of Medicine,University of Calgary,Calgary.
Eddy
E
Lang
26Department of Neurology,Université de Montréal,Montreal,Quebec.
Sylvain
S
Lanthier
20Heart and Stroke Foundation of Canada,Ottawa.
Patrice
P
Lindsay
4Calgary Stroke Program,Foothills Hospital,Calgary.
Nancy
N
Newcommon
22Kingston Department of Clinical Neurosciences,Western University,London.
Jennifer
J
Mandzia
6Faculty of Nursing,University of Alberta,Edmonton,Alberta.
Colleen M
CM
Norris
23Division of Neurology,Department of Medicine,McMaster University,Hamilton,Ontario.
Wes
W
Oczkowski
25Department of Neurosciences,Quebec.
Céline
C
Odier
27Faculty of Medicine (Neurology),Dalhousie University,Canada.
Stephen
S
Phillips
25Department of Neurosciences,Quebec.
Alexandre Y
AY
Poppe
16Stroke Research Unit,Toronto.
Gustavo
G
Saposnik
17Division of Neurology,Regional Stroke Program,St. Michael's Hospital,Toronto.
Daniel
D
Selchen
5Division of Neurology,Department of Medicine,University of Alberta,Edmonton,Alberta.
Ashfaq
A
Shuaib
11Department of Neurology,University of Toronto.
Frank
F
Silver
1Department of Clinical Neurosciences,University of Calgary,Calgary.
Eric E
EE
Smith
10Department of Medicine,University of Toronto.
Grant
G
Stotts
4Calgary Stroke Program,Foothills Hospital,Calgary.
Michael
M
Suddes
13Regional Stroke Program,Sunnybrook Health Sciences Centre,University of Toronto.
Richard H
RH
Swartz
8Division of Neurology, Faculty of Medicine,University of British Columbia,Vancouver,British Columbia.
Philip
P
Teal
1Department of Clinical Neurosciences,University of Calgary,Calgary.
Tim
T
Watson
1Department of Clinical Neurosciences,University of Calgary,Calgary.
Michael D
MD
Hill
D019985:Benchmarking / Q000379:methods / Q000592:standards*; D002170:Canada / Q000453:epidemiology; D006801:Humans; D009339:Needles; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D015912:Thrombolytic Therapy / Q000379:methods / Q000592:standards*; D061665:Time-to-Treatment / Q000592:standards*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
D010959:Tissue Plasminogen Activator